Biote Corp. Class A Share Price
NASDAQ: BTMDBiote Corp. Class A Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Biote Corp. Class A Share Price Chart
Biote Corp. Class A Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $0.86 | Revenue (TTM) $192.22M | Return On Equity (TTM) -53.98% |
Profit Margin 16.44% | Debt to Equity -0.77 | Quarterly Earnings Growth YoY -23.49% |
Biote Corp. Class A Quarterly Profit & Loss
All figures in USD
Biote Corp. Class A Annual Profit & Loss
All figures in USD
About Biote Corp. Class A
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Biote Corp. Class A Historical Returns
| Month | Open | Close | Change % |
|---|